Skip to content

NeoVentures Timeline

2023

Protein Production

Added in-house recombinant protein production
2023

Analysis

Added capacity in transcriptomics analysis of the effect of aptamers on cell lines
2022

Meta-Analysis

Creation of system for meta-analysis of aptamer selection
2022

Neomer Method

Invention of Neomer method of aptamer selection, a game-changing selection platform (patents filed on method and method of analysis)
2021

COVID Aptamers

Development of a catalogue of COVID aptamers
2021

Aptamer Applications

Development of aptamer applications with electrochemical techniques
2021

Method Invention

The invention of method to select aptamers that induce endocytosis for drug delivery
2020

Fluorescence Switching

Development of aptamer efficacy with fluorescence switching in the presence of graphene oxide
2020

Gold

Development of aptamer gold nanoparticle applications, lateral flow, flow through
2020

Aptamer Selection

The invention of method to select aptamers that do not induce endocytosis on transmembrane receptors, prophylactic applications
2020

Development

Development of aptamer quantum dot applications
2020

Barcelona

Development of Barcelona method, while flying to Barcelona, for multiple target selection
2018

Aptamarker Platform

NeoNeuro invents and patents the aptamarker platform, an agnostic approach for the identification of aptamers that bind to diagnostically meaningful targets
2015

BBB

The invention of BBB aptamers, pre-selected for capacity to penetrate the blood-brain barrier
2015

Paris, France

Founded NeoNeuro in Paris for the development of aptamer applications for neurodegenerative disease treatment and diagnosis
2014

FRELEX

Patented FRELAX, an aptamer selection method for small molecules in a free state
2013

Software Development

Developed NGS software. The first company to provide NGS service for aptamer discovery
2012

Aptamer Development

Launch of fee-for-service aptamer development services
2010

Commercial Launch

Follow up with the commercial launch of Rising Number test, an aptamer-based test for dough quality
2008

Commercialization

First commercialization of an aptamer based diagnostic, the MycoSense series of products
2005

Development

First successful Aptamers for small molecules Ochratoxin A & Aflatoxin B1 were developed
2002

NeoVenture Biotechnology Inc.

Incorporates in Canada